Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
Status:
Not yet recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
The TILE pilot study will be a multicenter, open-label, assessor-blinded RCT (randomized
control trial) comparing extended LMWH (Low Molecular Weight Heparin) vs. DOAC (Direct Oral
Anticoagulants) to PTS (prevent post thrombotic syndrome) in patients with DVT (Deep Vein
Thrombosis).